615
A 27-year-old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim (TMP)-sulfamethoxazole (SMX) treatment.
 A 27-year-old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia: Subject; 27-year-old: Subject.Age; man: Subject.Gender; bronchial asthma: Subject.Disorder; eosinophilic enteritis: Subject.Disorder; eosinophilic pneumonia: Subject.Disorder; fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia: Effect; trimethoprim (TMP)-sulfamethoxazole (SMX): Treatment; trimethoprim: Treatment.Drug; sulfamethoxazole: Treatment.Drug; two weeks after: Treatment.Time_elapsed; sulfamethoxazole: Combination.Drug; trimethoprim: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 A 27-year-old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia: Subject; 27-year-old: Subject.Age; man: Subject.Gender; bronchial asthma: Subject.Disorder; eosinophilic enteritis: Subject.Disorder; eosinophilic pneumonia: Subject.Disorder; fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia: Effect; trimethoprim (TMP)-sulfamethoxazole (SMX): Treatment; trimethoprim: Treatment.Drug; sulfamethoxazole: Treatment.Drug; two weeks after: Treatment.Time_elapsed; sulfamethoxazole: Combination.Drug; trimethoprim: Combination.Drug